{"_id": "53bc8d8f38f0d846b5b5d253", "print_page": null, "blog": [], "byline": {"person": [], "organization": "REUTERS", "original": "By REUTERS"}, "multimedia": [], "source": "Reuters", "type_of_material": "News", "news_desk": null, "snippet": "Pfizer Inc won the dismissal Tuesday of a long-running shareholder class action accusing the company of misleading investors about the safety of its Celebrex and Bextra pain-relieving drugs....", "document_type": "article", "subsection_name": null, "word_count": "441", "headline": {"print_headline": "Pfizer Wins Dismissal of U.S. Investor Class Action Ahead of Trial", "main": "Pfizer Wins Dismissal of U.S. Investor Class Action Ahead of Trial"}, "lead_paragraph": "Pfizer Inc won the dismissal Tuesday of a long-running shareholder class action accusing the company of misleading investors about the safety of its Celebrex and Bextra pain-relieving drugs.", "slideshow_credits": null, "keywords": [], "pub_date": "2014-07-08T20:30:12Z", "section_name": "Business Day", "abstract": null, "web_url": "http://www.nytimes.com/reuters/2014/07/08/business/08reuters-pfizer-classaction.html"}